April 2021 vol 27 no 3

Type 2 diabetes: Two new medications offer fresh management paradigm

April 1, 2021

Current international guidelines for type 2 diabetes management include the use of two new classes of medication: sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists, in people with established kidney disease, heart disease or heart failure, or with high cardiovascular risk.1

Read more... Type 2 diabetes: Two new medications offer fresh management paradigm